Dr. Linette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Pennsylvania
3400 Civic Center Blvd. Building 421
Philadelphia, PA 19104Phone+1 215-573-4148
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1997
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1993 - 1995- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1990 - 1992
Georgetown University School of MedicineClass of 1990
Certifications & Licensure
PA State Medical License 2016 - 2024
MO State Medical License 2001 - 2017
MA State Medical License 1998 - 2006- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma Start of enrollment: 2008 Aug 01
- DC Vaccine in Pancreatic Cancer Start of enrollment: 2018 Nov 20
Publications & Presentations
PubMed
- 10975 citationsImproved Survival with Ipilimumab in Patients with Metastatic Melanoma.F. Stephen Hodi, Steven J. O'Day, David F. McDermott, R. W. Weber, Jeffrey A. Sosman
The New England Journal of Medicine. 2010-08-18 - 906 citationsIpilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging studyJedd D. Wolchok, Bart Neyns, Gerald P. Linette, Sylvie Negrier, Jose Lutzky
The Lancet. Oncology. 2010-02-01 - 214 citationsAdjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomi...Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson
The Lancet. Oncology. 2021-05-01
Press Mentions
Awards & Accolades: July 2021August 4th, 2021- Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising InvestigatorsJuly 15th, 2021
- BostonGene Announces Cancer Research Collaboration with the Abramson Cancer Center of the University of PennsylvaniaMay 11th, 2021
- Join now to see all
Grant Support
- PD-1 inhibition after Neoantigen VaccineNCIPresent
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
